Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference9 articles.
1. Cuckle HS, Pergament E, Benn P. Multianalyte maternal serum screening for chromosomal abnormalities and neural tube defects. In: Milunsky A, Milunsky JM, editors. Genetic disorders and the fetus: diagnosis, prevention and treatment. 7th ed. Hoboken: Wiley-Blackwell; 2015.
2. Donalson K, Turner S, Morrison L, et al. Maternal serum placental growth factor and α-fetoprotein testing in first trimester screening for Down’s syndrome. Prenat Diagn. 2013;33:1–5.
3. Johnson J, Pastuck M, Metcalf A, et al. New approaches to first trimester Down’s syndrome screening using additional serum markers and cell free DNA. Prenat Diagn. 2013;33:1044–9.
4. Huang T, Dennis A, Meschino WS, et al. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor and α-fetoprotein. Prenat Diagn. 2015;35(7):709–16.
5. O’Gorman N, Wright D, Poon LC, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017;49(6):751–5.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献